Loading ETF profile…
The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| PAGP | PLAINS GP HLDGS L P | 41.76% | $29.79M |
| ACHV | ACHIEVE LIFE SCIENCES INC USD 0.001 | 10.64% | $7.59M |
| MIST | MILESTONE PHARMACEUTICALS INC NPV | 5.96% | $4.25M |
| DCTH | DELCATH SYS INC USD 0.01 | 4.48% | $3.20M |
| CORT | CORCEPT THERAPEUTICS INC USD 0.001 | 4.32% | $3.08M |
| ABEO | ABEONA THERAPEUTICS INC USD 0.01 | 3.93% | $2.80M |
| PHAT | PHATHOM PHARMACEUTICALS USD 0.0001 | 3.71% | $2.64M |
| — | ACHIEVE LIFE SCIENCES I WTS 30JUN30 | 3.12% | $2.22M |
| CLDX | CELLDEX THERAPEUTICS INC USD 0.001 | 2.80% | $1.99M |
| KYTX | KYVERNA THERAPEUTICS IN USD 0.00001 | 2.21% | $1.57M |
| CMPS | COMPASS PATHWAYS PLC USD 0.008 ADR | 2.02% | $1.44M |
| AQST | AQUESTIVE THERAPEUTICS IN USD 0.001 | 1.95% | $1.39M |
| LONA | LEONABIO INC USD 0.0001 | 1.80% | $1.28M |
| ZVRA | ZEVRA THERAPEUTICS INC USD 0.0001 | 1.77% | $1.26M |
| PALI | PALISADE BIO INC USD 0.01 | 1.73% | $1.24M |
| IVA | INVENTIVA SA NPV ADR | 1.52% | $1.08M |
| ARTV | ARTIVA BIOTHERAPEUTICS I USD 0.0001 | 1.32% | $944.63K |
| — | TELSAT 5.625 12/06/26 144A Corp | 1.25% | $893.79K |
| OBIO | ORCHESTRA BIOMED HLDGS I USD 0.0001 | 1.22% | $873.16K |
| OCUL | OCULAR THERAPEUTIX INC USD 0.0001 | 1.12% | $798.35K |
| EYPT | EYEPOINT INC | 0.92% | $653.89K |
| IMUX | IMMUNIC INC USD 0.0001 | 0.91% | $645.67K |
| SABS | SAB BIOTHERAPEUTICS INC USD 0.0001 | 0.81% | $575.17K |
| — | ACHIEVE LIFE SCIENCES WTS | 0.62% | $443.19K |
| — | AKERO THERAPEUTICS INC CVR | 0.60% | $426.63K |